If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Lyumjev ® (insulin lispro - aabc) injection
100 units/mL, 200 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is Lyumjev® (insulin lispro-aabc) approved to be used in a pump?
Since August 13, 2021, Lyumjev 100 units/mL is approved for use in an insulin pump.
Lyumjev Approval for Use in an Insulin Pump
Since August 13, 2021, Lyumjev 100 units/mL has been approved to be used in insulin pumps in the United States.1
Lyumjev 100 units/mL should be administered in accordance with the instructions provided by the pump manufacturer. Refer to the continuous subcutaneous insulin infusion pump user manual to see if Lyumjev can be used with the insulin pump.1
Do not administer Lyumjev 200 units/mL using an insulin pump.1
Enclosed Prescribing Information
Reference
1Lyumjev [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: August 13, 2021